Article

Growth is forecast: Alcon IPO raises $2.5 billion in partial Nestle divestiture

Fort Worth, TX-Alcon Inc.'s successful initial public offering (IPO) not only confirms the stability of the company, but positions it well for future growth and investment, according to company officials and analysts.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Tiimes) EyeCon 2025: Sruthi Arepalli, MD, spotlights a deep dive orbital tour of the eye
© 2025 MJH Life Sciences

All rights reserved.